よむ、つかう、まなぶ。
資料２－２－４ 医療機器研究報告［1.8MB］ (49 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_53225.html |
| 出典情報 | 薬事審議会 医療機器・再生医療等製品安全対策部会（令和6年度第2回 3／6）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
医療機器研究報告
番号
医療機器の一般名
文献名
481
植込み型除細動器・ペースメーカリード
【Heart Rhythm 2024;21:419–426, https://doi.org/10.1016/j.hrthm.2023.12.009】Left bundle branch pacing lead for
sensing ventricular arrhythmias in implantable cardioverter-defibrillator: A pilot study (LBBP-ICD study)
482
中心循環系マイクロカテーテル
【Frontiers in Neurology. 2023 Nov 17:14:1256365. doi: 10.3389/fneur.2023.1256365】Evaluation of effectiveness and
safety of the large-format pRESET 6-50 thrombectomy stent-retriever in the endovascular treatment of ischemic
stroke: real-world experiences from two tertiary comprehensive stroke centers
483
中心循環系ガイディング用血管内カテーテル
【Acta Neurochirurgica (Wien). 2023 Aug;165(8):2077-2086. doi: 10.1007/s00701-023-05668-6】WEB (Woven
EndoBridge) device for intracranial aneurysm treatment: technical, radiological, and clinical findings in a consecutive
North American cohort
484
中心循環系血管内塞栓促進用補綴材
【World Neurosurgery. 2023 Oct:178:e465-e471. doi: 10.1016/j.wneu.2023.07.101】Early Termination versus Standard
Regimen Duration of Dual Antiplatelet Therapy in Intracranial Aneurysm Patients Treated With Pipeline Embolization
Device Flex With Shield Technology: Preliminary Experience of 3 U.S. Centers
485
中心循環系血管内塞栓促進用補綴材
【Journal of Neurosurgery. 2024 Jan 5;141(1):175-183. doi: 10.3171/2023.10.JNS231837】Predictors of occlusion,
long-term outcomes, and safety in a cohort of 674 aneurysms treated with the Pipeline embolization device
486
経カテーテルブタ心のう膜弁
【JACC: Cardiovascular Interventions, VOL. 17, NO. 14, 2024】3-Year Outcomes From the Evolut Low Risk TAVR
Bicuspid Study
487
経カテーテルブタ心のう膜弁
【JACC: Cardiovascular Interventions, VOL. 17, NO. 14, 2024】3-Year Outcomes From the Evolut Low Risk TAVR
Bicuspid Study
488
中心循環系血管内塞栓促進用補綴材
【Journal of NeuroInterventional Surgery. 2019 Jun;11(6):610-613.】The occurrence of neointimal hyperplasia after
flowdiverter implantation is associated with cardiovascular risks factors and the stent design
489
中心循環系血管内塞栓促進用補綴材
【Frontiers in Neurology. 2024 Jan 4:14:1278366. doi: 10.3389/fneur.2023.1278366】Safety and efficacy analysis of
the off-label use of pipeline embolization devices for intracranial aneurysms: a propensity score matching study
490
中心循環系血管内塞栓促進用補綴材
【Interventional Neuroradiology. 2023 Aug 27:15910199231196621. doi: 10.1177/15910199231196621】Comparison of
pipeline embolization device, flow re-direction endoluminal device and surpass flow diverters in the treatment of
intracerebral aneurysms
49 / 199
番号
医療機器の一般名
文献名
481
植込み型除細動器・ペースメーカリード
【Heart Rhythm 2024;21:419–426, https://doi.org/10.1016/j.hrthm.2023.12.009】Left bundle branch pacing lead for
sensing ventricular arrhythmias in implantable cardioverter-defibrillator: A pilot study (LBBP-ICD study)
482
中心循環系マイクロカテーテル
【Frontiers in Neurology. 2023 Nov 17:14:1256365. doi: 10.3389/fneur.2023.1256365】Evaluation of effectiveness and
safety of the large-format pRESET 6-50 thrombectomy stent-retriever in the endovascular treatment of ischemic
stroke: real-world experiences from two tertiary comprehensive stroke centers
483
中心循環系ガイディング用血管内カテーテル
【Acta Neurochirurgica (Wien). 2023 Aug;165(8):2077-2086. doi: 10.1007/s00701-023-05668-6】WEB (Woven
EndoBridge) device for intracranial aneurysm treatment: technical, radiological, and clinical findings in a consecutive
North American cohort
484
中心循環系血管内塞栓促進用補綴材
【World Neurosurgery. 2023 Oct:178:e465-e471. doi: 10.1016/j.wneu.2023.07.101】Early Termination versus Standard
Regimen Duration of Dual Antiplatelet Therapy in Intracranial Aneurysm Patients Treated With Pipeline Embolization
Device Flex With Shield Technology: Preliminary Experience of 3 U.S. Centers
485
中心循環系血管内塞栓促進用補綴材
【Journal of Neurosurgery. 2024 Jan 5;141(1):175-183. doi: 10.3171/2023.10.JNS231837】Predictors of occlusion,
long-term outcomes, and safety in a cohort of 674 aneurysms treated with the Pipeline embolization device
486
経カテーテルブタ心のう膜弁
【JACC: Cardiovascular Interventions, VOL. 17, NO. 14, 2024】3-Year Outcomes From the Evolut Low Risk TAVR
Bicuspid Study
487
経カテーテルブタ心のう膜弁
【JACC: Cardiovascular Interventions, VOL. 17, NO. 14, 2024】3-Year Outcomes From the Evolut Low Risk TAVR
Bicuspid Study
488
中心循環系血管内塞栓促進用補綴材
【Journal of NeuroInterventional Surgery. 2019 Jun;11(6):610-613.】The occurrence of neointimal hyperplasia after
flowdiverter implantation is associated with cardiovascular risks factors and the stent design
489
中心循環系血管内塞栓促進用補綴材
【Frontiers in Neurology. 2024 Jan 4:14:1278366. doi: 10.3389/fneur.2023.1278366】Safety and efficacy analysis of
the off-label use of pipeline embolization devices for intracranial aneurysms: a propensity score matching study
490
中心循環系血管内塞栓促進用補綴材
【Interventional Neuroradiology. 2023 Aug 27:15910199231196621. doi: 10.1177/15910199231196621】Comparison of
pipeline embolization device, flow re-direction endoluminal device and surpass flow diverters in the treatment of
intracerebral aneurysms
49 / 199